DONG-A ST CO. LTD 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-16 4:46 pm Sale |
2022-09-14 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO |
DONG-A ST CO. LTD | 12,003 10.700% |
-0 (-0.00%) |
Filing |
| 2021-09-01 4:20 pm Unchanged |
2021-09-01 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO |
DONG-A ST CO. LTD | 12,003 12.900% |
0 (Unchanged) |
Filing |
| 2021-08-27 9:11 pm Unchanged |
2021-08-27 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO |
DONG-A ST CO. LTD | 12,003 12.900% |
0 (Unchanged) |
Filing |
| 2021-03-11 06:08 am Unchanged |
2021-03-09 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO |
DONG-A ST CO. LTD | 12,003 13.000% |
0 (Unchanged) |
Filing |